Chung‐Pu Wu

4.6k total citations
86 papers, 3.8k citations indexed

About

Chung‐Pu Wu is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chung‐Pu Wu has authored 86 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 44 papers in Molecular Biology and 27 papers in Infectious Diseases. Recurrent topics in Chung‐Pu Wu's work include Drug Transport and Resistance Mechanisms (67 papers), HIV/AIDS drug development and treatment (27 papers) and Cancer therapeutics and mechanisms (26 papers). Chung‐Pu Wu is often cited by papers focused on Drug Transport and Resistance Mechanisms (67 papers), HIV/AIDS drug development and treatment (27 papers) and Cancer therapeutics and mechanisms (26 papers). Chung‐Pu Wu collaborates with scholars based in Taiwan, United States and United Kingdom. Chung‐Pu Wu's co-authors include Suresh V. Ambudkar, Anna Maria Calcagno, Chia‐Hung Hsieh, Suneet Shukla, Yu-Shan Wu, Tai‐Ho Hung, Sung-Han Hsiao, Stephen B. Hladky, Margery A. Barrand and Yang-Hui Huang and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemistry and Cancer Research.

In The Last Decade

Chung‐Pu Wu

85 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chung‐Pu Wu Taiwan	32	2.3k	1.9k	561	383	380	86	3.8k
Suneet Shukla United States	41	3.4k 1.5×	2.3k 1.2×	902 1.6×	275 0.7×	728 1.9×	77	5.1k
Rolf W. Sparidans Netherlands	35	2.0k 0.9×	1.6k 0.8×	364 0.6×	251 0.7×	397 1.0×	169	4.2k
Catherine Booth-Genthe United States	10	1.8k 0.8×	1.7k 0.9×	287 0.5×	366 1.0×	315 0.8×	13	3.3k
Dong‐Hua Yang United States	41	2.1k 0.9×	3.2k 1.7×	356 0.6×	813 2.1×	273 0.7×	184	5.8k
Zhi Shi China	42	1.6k 0.7×	2.4k 1.3×	218 0.4×	635 1.7×	179 0.5×	122	4.3k
Ahmad R. Safa United States	43	3.8k 1.6×	3.8k 2.0×	577 1.0×	543 1.4×	720 1.9×	130	6.1k
Tomoyuki Sumizawa Japan	38	2.7k 1.2×	2.2k 1.2×	255 0.5×	813 2.1×	471 1.2×	94	4.6k
Hermann Lage Germany	45	3.1k 1.4×	4.2k 2.2×	341 0.6×	955 2.5×	372 1.0×	173	6.7k
Janice E. Chin United States	18	3.1k 1.3×	2.4k 1.3×	550 1.0×	205 0.5×	621 1.6×	22	4.4k
Peter Charlton United Kingdom	34	2.1k 0.9×	2.7k 1.4×	346 0.6×	628 1.6×	452 1.2×	74	4.5k

Countries citing papers authored by Chung‐Pu Wu

Since Specialization

Citations

This map shows the geographic impact of Chung‐Pu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Pu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Pu Wu more than expected).

Fields of papers citing papers by Chung‐Pu Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Pu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Pu Wu. The network helps show where Chung‐Pu Wu may publish in the future.

Co-authorship network of co-authors of Chung‐Pu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Pu Wu. A scholar is included among the top collaborators of Chung‐Pu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Pu Wu. Chung‐Pu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murakami, Megumi, Yu‐Shan Wu, Tai‐Ho Hung, et al.. (2024). Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2. European Journal of Pharmacology. 988. 177231–177231.

Wu, Chung‐Pu, Ya‐Ju Hsieh, Megumi Murakami, et al.. (2023). ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines. Cells. 12(7). 1056–1056. 7 indexed citations

Wu, Chung‐Pu, Megumi Murakami, Yu‐Shan Wu, et al.. (2022). P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhibitor Ensartinib in Cancer Cells. Cancers. 14(9). 2341–2341. 11 indexed citations

Wu, Chung‐Pu, Sabrina Lusvarghi, Sung-Han Hsiao, et al.. (2021). Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat. International Journal of Molecular Sciences. 22(5). 2592–2592. 10 indexed citations

Hung, Tai‐Ho, et al.. (2019). Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis. Mediators of Inflammation. 2019. 1–13. 3 indexed citations

Wu, Chung‐Pu, Megumi Murakami, Sung-Han Hsiao, et al.. (2018). SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters. 433. 259–272. 18 indexed citations

Hsieh, Chia‐Hung, Yu‐Jung Lin, Chung‐Pu Wu, et al.. (2014). Livin Contributes to Tumor Hypoxia–Induced Resistance to Cytotoxic Therapies in Glioblastoma Multiforme. Clinical Cancer Research. 21(2). 460–470. 45 indexed citations

Wu, Chung‐Pu, et al.. (2014). Human ATP-Binding Cassette transporters ABCB1 and ABCG2 confer resistance to CUDC-101, a multi-acting inhibitor of histone deacetylase, epidermal growth factor receptor and human epidermal growth factor receptor 2. Biochemical Pharmacology. 92(4). 567–576. 28 indexed citations

Fukuda, Yu, Kazumasa Takenaka, Alex Sparreboom, et al.. (2013). Human Immunodeficiency Virus Protease Inhibitors Interact with ATP Binding Cassette Transporter 4/Multidrug Resistance Protein 4: A Basis for Unanticipated Enhanced Cytotoxicity. Molecular Pharmacology. 84(3). 361–371. 32 indexed citations

10.

Wu, Chung‐Pu, Sung-Han Hsiao, Hong‐May Sim, et al.. (2013). Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1. Biochemical Pharmacology. 86(7). 904–913. 29 indexed citations

11.

Wu, Chung‐Pu, Hong‐May Sim, Yang-Hui Huang, et al.. (2012). Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochemical Pharmacology. 85(3). 325–334. 58 indexed citations

12.

Wu, Chung‐Pu, Shinobu Ohnuma, & Suresh V. Ambudkar. (2011). Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy. Current Pharmaceutical Biotechnology. 12(4). 609–620. 145 indexed citations

13.

Mi, Yan‐jun, Yong‐ju Liang, Hong-Yun Zhao, et al.. (2010). Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters. Cancer Research. 70(20). 7981–7991. 288 indexed citations

14.

Calcagno, Anna Maria, Crystal D. Salcido, Jean-Pierre Gillet, et al.. (2010). Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics. JNCI Journal of the National Cancer Institute. 102(21). 1637–1652. 226 indexed citations

15.

Orina, Josiah N., Anna Maria Calcagno, Chung‐Pu Wu, et al.. (2009). Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Molecular Cancer Therapeutics. 8(7). 2057–2066. 31 indexed citations

16.

Dai, Chun-ling, Yong‐ju Liang, Xu Zhang, et al.. (2009). Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function. Biochemical Pharmacology. 78(4). 355–364. 25 indexed citations

17.

Dai, Chun-ling, Amit K. Tiwari, Chung‐Pu Wu, et al.. (2008). Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2. Cancer Research. 68(19). 7905–7914. 333 indexed citations

18.

Calcagno, Anna Maria, et al.. (2006). Plasma membrane calcium ATPase (PMCA4): A housekeeper for RT-PCR relative quantification of polytopic membrane proteins. BMC Molecular Biology. 7(1). 29–29. 19 indexed citations

19.

Wu, Chung‐Pu, Antonios Klokouzas, Stephen B. Hladky, Suresh V. Ambudkar, & Margery A. Barrand. (2005). Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochemical Pharmacology. 70(4). 500–510. 58 indexed citations

20.

Klokouzas, Antonios, Chung‐Pu Wu, Hendrik W. van Veen, Margery A. Barrand, & Stephen B. Hladky. (2003). cGMP and glutathione‐conjugate transport in human erythrocytes. European Journal of Biochemistry. 270(18). 3696–3708. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact